To what causes do people attribute their chronic breathlessness? A population survey

Journal of Palliative Medicine

Volumn 15, Issue 7, 2012, Pages 744-750

  Johnson, Miriam J ^a   Bowden, Jacqueline A ^b   Abernethy, Amy P ^c,d   Currow, David C ^d  

^a UNIVERSITY OF HULL   (United Kingdom)

^b Cancer Council South Australia   (Australia)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d FLINDERS UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AUSTRALIA; CHRONIC DISEASE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE DURATION; DYSPNEA; FEMALE; HEALTH CARE UTILIZATION; HEALTH SERVICE; HEALTH SURVEY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MODIFIED MEDICAL RESEARCH COUNCIL (BREATHLESSNESS) SCALE; PREVALENCE; REVIEW;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; DYSPNEA; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SURVEYS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; SOUTH AUSTRALIA; YOUNG ADULT;

EID: 84863789647     PISSN: 10966218     EISSN: 15577740     Source Type: Journal    
DOI: 10.1089/jpm.2011.0430     Document Type: Review

References (34)

1. Currow DC, Plummer JL, Crockett A, Abernethy AP: A community population survey of prevalence and severity of dyspnea in adults. J Pain Symptom Manage 2009;38: 533-545.
2. National Institute for Health and Clinical Excellence. Chronic heart failure: Management of chronic heart failure in adults in primary and secondary care. 2010 guidance.nice .org.uk/CG108. (Last accessed May 22, 2012.
3. National Institute for Health and Clinical Excellence. Management of chronic obstructive pulmonary disease in adults in primary and secondary care (partial update). 2010 guidance. nice.org.uk/CG101. (Last accessed May 22, 2012.
4. Johnson MJ, McDonagh TA, Harkness A, McKay SE, Dargie HJ: Morphine for the relief of breathlessness in patients with chronic heart failure-a pilot study. Eur J Heart Fail 2002;4:753-756.
5. Abernethy AP, Currow DC, Frith P, Fazekas BS, McHugh A, Bui C: Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. BMJ 2003;327:523-528.
6. Bausewein C, Booth S, Gysels M, Higginson I: Nonpharmacological interventions for breathlessness in advanced stages of malignant and non-malignant diseases. Cochrane Database Syst Rev 2008;2:CD005623.
7. Galbraith S, Fagan P, Perkins P, Lynch A, Booth S: Does the use of a handheld fan improve chronic dyspnea? A randomized, controlled, crossover trial. J Pain Symptom Manage 2010;39:831-838.
8. Jennings AL, Davies AN, Higgins JP, Gibbs JS, Broadley KE: A systematic review of the use of opioids in the management of dyspnoea. Thorax 2002;57:939-944.
9. Tod AM, Joanne R: Overcoming delay in the diagnosis of lung cancer: A qualitative study. Nurs Stand 2010;24:35-43.
10. Richards H, Reid M, Watt G: Victim-blaming revisited: A qualitative study of beliefs about illness causation, and responses to chest pain. Fam Pract 2003;20:711-716.
11. Bergh KD: The patient's differential diagnosis. Unpredictable concerns in visits for acute cough. J Fam Pract 1998;46:153-158.
12. Kessler D, Lloyd K, Lewis G, Gray DP: Cross sectional study of symptom attribution and recognition of depression and anxiety in primary care BMJ 1999;318:436-439.
13. Marple RL, Kroenke K, Lucey CR, Wilder J, Lucas CA: Concerns and expectations in patients presenting with physical complaints. Frequency, physician perceptions and actions, and 2-week outcome. Arch Intern Med 1997;157: 1482-1488.
14. Gysels M, Higginson IJ: Access to services for patients with chronic obstructive pulmonary disease: The invisibility of breathlessness. J Pain Symptom Manage 2008;36:451-460.
15. Gysels M, Higginson IJ: The experience of breathlessness: The social course of chronic obstructive pulmonary disease. J Pain Symptom Manage 2010;39:555-563.
16. Gysels MH, Higginson IJ: Caring for a person in advanced illness and suffering from breathlessness at home: Threats and resources. Palliat Support Care 2009 Jun;7:153-162.
17. Anon. Australian Demographic Statistics. Australian Bureau of Statistics. www.abs.gov.au/ausstats/abs@nsf (Last accessed March 22, 2007).
18. Blyth FM, March LM, Brnabic AJ, Jorm LR, Williamson M, Cousins MJ: Chronic pain in Australia: A prevalence study. Pain 2001;89:127-134.
19. Australian Institute of Health and Welfare. Australia's health 2010. The 12th biennial health report of the Australian Institute of Health and Welfare. 2010. Cat. No. AUS 122. Canberra. www.aihw.gov.au/publication-detail/?id = 6442468376 (Last accessed June 27, 2011).
20. Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Clausen H: Dying of lung cancer or cardiac failure: Prospective qualitative interview study of patients and their carers in the community. BMJ 2002;325:929.
21. Rogers A, Addington-Hall JM, McCoy AS, Edmonds PM, Abery AJ, Coats AJ, Gibbs JS: A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. Eur J Heart Fail 2002;4:283-287.
22. Buist AS, McBurnie MA, Vollmer WM, Gillespie S, Burney P, Mannino DM, Menezes AM, Sullivan SD, Lee TA, Weiss KB, Jensen RL, Marks GB, Gulsvik A, Nizankowska-Mogilnicka E; BOLD Collaborative Research Group: International variation in the prevalence of COPD (the BOLD Study): A population-based prevalence study. Lancet 2007; 370:741-750.
23. Australian Bureau of Statistics. ABS Survey of Disability, Ageing and Carers (SDAC), 2003. www.ausstats.abs.gov .au/Ausstats/subscriber.nsf/0/ 978A7C78CC11B702CA256 F0F007B1311/File/44300-2003.pdf. (Last accessed May 22, 2012.
24. O'Halloran J, Ng A, Britt H, Charles J: EPC encounters in Australian general practice Aust Fam Physician 2006;35:8-10.
25. Scottish Public Health Observatory. Chronic obstructive pulmonary disease (COPD): Primary care data. 2010. www.scotpho.org.uk/home/Healthwell- beinganddisease/copd/ copd-data/copd-primarycare.asp. (Last accessed May 22, 2012.
26. Australian Institute of Health and Welfare. Australia's Health 2010. The twelfth biennial health report of the Australian Institute of Health and Welfare. Canberra; May 2010 www.aihw.gov.au/publications/aus/ah10/ah10.pdf. (Last accessed May 22, 2012.
27. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS, Conway WA Jr, Enright PL, Kanner RE, O'Hara P, et al.: Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. The Lung Health Study. JAMA 1994;272: 1497-1505.
28. Man SF, McAlister FA, Anthonisen NR, Sin DD: Contemporary management of chronic fobstructive pulmonary disease: Clinical applications. JAMA 2003;290:2313-2316.
29. Casas A, Troosters T, Garcia-Aymerich J, Roca J, Hernandez C, Alonso A, del Pozo F, de Toledo P, Antó JM, Rodríguez-Roisín R, Decramer M; members of the CHRONIC Project: Integrated care prevents hospitalisations for exacerbations in COPD patients Eur Respir J 2006;28:123-130.
30. Zhou Y, Hu G, Wang D, Wang S, Wang Y, Liu Z, Hu J, Shi Z, Peng G, Liu S, Lu J, Zheng J, Wang J, Zhong N, Ran P: Community based integrated intervention for prevention and management of chronic obstructive pulmonary disease (COPD) in Guangdong, China: Cluster randomised controlled trial. BMJ 2010;341:c6387.
31. Charles J, Ng A, Britt H: Presentations of shortness of breath in Australian general practice. Aust Fam Physician 2005; 34:520-521.
32. NHS Employers: Quality and Outcomes Framework; guidance for GMS contract 2009/10. Delivering investment in general practice. March 2009. www.nhsemployers.org/ PayAndContracts/GeneralMedicalServicescontract/qof/ Pages/QualityOutcomesFramework.aspx. (Last accessed May 22, 2012.
33. Uronis H, McCrory DC, Samsa G, Currow D, Abernethy A: Symptomatic oxygen for non-hypoxaemic chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2011;6: CD006429.
34. Hospital Quarterly: Performance of NSW public hospitals, January to March 2011 www.bhi.nsw.gov.au/publications/ hospital-quarterly-vol-2-issue-1 (Last accessed June 27, 2011).